Mannkind MNKD
NASDAQ MNKD
$3.95 +0.05 (+1.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Mannkind (MNKD) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Mannkind's Liabilities and Shareholders Equity came in at $732.3 million for Q2 2026, up 77.9% from $411.7 million a year earlier but down 1.6% from the prior quarter.

Analysis

Mannkind (MNKD) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Mannkind's Liabilities and Shareholders Equity was $792.18 million, up 101.1% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 48.8% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $393.84 million in FY2024 (-17.1%), $475.2 million in FY2023 (+60.9%), $295.28 million in FY2022 (-8.1%) and $321.16 million in FY2021 (+195.7%).
  • The five-year range for quarterly Liabilities and Shareholders Equity is $238.21 million (Q3 2021) to $792.18 million (Q4 2025).
  • Year-over-year, Liabilities and Shareholders Equity has increased for four consecutive quarters, with growth averaging 34.1% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q4 2021 (growth of 195.7%), and the weakest in Q4 2024 (a decline of 17.1%).
  • Business Quant data shows MNKD's Liabilities and Shareholders Equity at $744.4 million (Q1 2026), $792.18 million (Q4 2025) and $494.64 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Mannkind 1.21 Bn 529.30 Mn 94.97 Mn 732.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 732.30 Mn
Mar 31, 2026 744.40 Mn
Dec 31, 2025 792.18 Mn
Sep 30, 2025 494.64 Mn
Jun 30, 2025 411.70 Mn
Mar 31, 2025 410.14 Mn
Dec 31, 2024 393.84 Mn
Sep 30, 2024 464.20 Mn
Jun 30, 2024 443.84 Mn
Mar 31, 2024 480.88 Mn
Dec 31, 2023 475.20 Mn
Sep 30, 2023 320.33 Mn
Jun 30, 2023 313.42 Mn
Mar 31, 2023 298.14 Mn
Dec 31, 2022 295.28 Mn
Sep 30, 2022 293.84 Mn
Jun 30, 2022 285.80 Mn
Mar 31, 2022 308.32 Mn
Dec 31, 2021 321.16 Mn
Sep 30, 2021 238.21 Mn
API Access

Mannkind Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MNKD&period=max&api_key=YOUR_API_KEY